Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Research and Practice in Thrombosis and Haemostasis|July 21, 2020
A risk score for prediction of venous thromboembolism in gynecologic cancer: The Thrombogyn scoreLucy A Norris, Mark P Ward, Sharon A O'Toole, et al.
Acta Obstetricia Et Gynecologica Scandinavica|February 16, 2021
The value of human epididymis 4, D-dimer, and fibrinogen compared with CA 125 alone in triaging women presenting with pelvic masses: a retrospective cohort studyKate McKendry, Stephen Duff, Yanmei Huang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 15, 2018
The Clearance of Serum Human Epididymis Protein 4 Following Primary Cytoreductive Surgery for Ovarian CarcinomaClaire Thompson, Waseem Kamran, Lucy Dockrell, et al.
Tumori|March 7, 2015
Neoadjuvant crizotinib in advanced inflammatory myofibroblastic tumour with ALK gene rearrangementShereen Rafee, Yasir Y Elamin, Eimear Joyce, et al.
Breast (Edinburgh, Scotland)|May 17, 2011
Surgical management of an Irish cohort of BRCA-mutation carriersPaul A Carroll, Carmel Nolan, Roisin Clarke, et al.
Cancer Letters|December 3, 2014
A novel serum microRNA panel to discriminate benign from malignant ovarian diseaseReam Langhe, Lucy Norris, Feras Abu Saadeh, et al.
Molecular Cancer|April 30, 2008
Potential role of miR-9 and miR-223 in recurrent ovarian cancerAlexandros Laios, Sharon O'Toole, Richard Flavin, et al.
Obstetrics & Gynecology Science|September 3, 2020
Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancerRoshni D Kalachand, Ciaran O'Riain, Sinead Toomey, et al.
Gynecologic Oncology|November 20, 2020
HE4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: A retrospective study in a cohort with histological proof of lymph node statusSharon A O'Toole, Yanmei Huang, Lucy Norris, et al.
Scientific Reports|March 6, 2023
Ex vivo expansion of circulating tumour cells (CTCs)Bashir M Mohamed, Mark P Ward, Mark Bates, et al.
Pageof 4